PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP

An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DE BRUYN, MARCEL F. L, YAMAGUCHI, MIKAKO, BONGARTZ, JEAN-PIERRE A. M, KENNIS, LUDO E.J, HENDRICKX, ROBERT J. M, OKUBO, TAKETOSHI, LUYCKX, MARCEL G. M, NAKAZATO, ATSURO, NOZAWA, DAI, TAMITA, TOMOKO, VAN DEN KEYBUS, FRANS M. A, VAN ROOSBROECK, YVES E. M
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DE BRUYN, MARCEL F. L
YAMAGUCHI, MIKAKO
BONGARTZ, JEAN-PIERRE A. M
KENNIS, LUDO E.J
HENDRICKX, ROBERT J. M
OKUBO, TAKETOSHI
LUYCKX, MARCEL G. M
NAKAZATO, ATSURO
NOZAWA, DAI
TAMITA, TOMOKO
VAN DEN KEYBUS, FRANS M. A
VAN ROOSBROECK, YVES E. M
description An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. [SOLUTION] A pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1467997B8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1467997B8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1467997B83</originalsourceid><addsrcrecordid>eNrjZAgNiAwK8vfxB1Kevp4unn6uCo5-LgpIomAxF9cgzzDHEM8w12CF4FCn4BDPkNAQVxeFcM8QDwXnSGcfT2cFR19PP38F9yD_0AAeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBoYmZuaWnuZGFMhBIAn6MxQw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP</title><source>esp@cenet</source><creator>DE BRUYN, MARCEL F. L ; YAMAGUCHI, MIKAKO ; BONGARTZ, JEAN-PIERRE A. M ; KENNIS, LUDO E.J ; HENDRICKX, ROBERT J. M ; OKUBO, TAKETOSHI ; LUYCKX, MARCEL G. M ; NAKAZATO, ATSURO ; NOZAWA, DAI ; TAMITA, TOMOKO ; VAN DEN KEYBUS, FRANS M. A ; VAN ROOSBROECK, YVES E. M</creator><creatorcontrib>DE BRUYN, MARCEL F. L ; YAMAGUCHI, MIKAKO ; BONGARTZ, JEAN-PIERRE A. M ; KENNIS, LUDO E.J ; HENDRICKX, ROBERT J. M ; OKUBO, TAKETOSHI ; LUYCKX, MARCEL G. M ; NAKAZATO, ATSURO ; NOZAWA, DAI ; TAMITA, TOMOKO ; VAN DEN KEYBUS, FRANS M. A ; VAN ROOSBROECK, YVES E. M</creatorcontrib><description>An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. [SOLUTION] A pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.</description><language>eng ; fre ; ger</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080827&amp;DB=EPODOC&amp;CC=EP&amp;NR=1467997B8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080827&amp;DB=EPODOC&amp;CC=EP&amp;NR=1467997B8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DE BRUYN, MARCEL F. L</creatorcontrib><creatorcontrib>YAMAGUCHI, MIKAKO</creatorcontrib><creatorcontrib>BONGARTZ, JEAN-PIERRE A. M</creatorcontrib><creatorcontrib>KENNIS, LUDO E.J</creatorcontrib><creatorcontrib>HENDRICKX, ROBERT J. M</creatorcontrib><creatorcontrib>OKUBO, TAKETOSHI</creatorcontrib><creatorcontrib>LUYCKX, MARCEL G. M</creatorcontrib><creatorcontrib>NAKAZATO, ATSURO</creatorcontrib><creatorcontrib>NOZAWA, DAI</creatorcontrib><creatorcontrib>TAMITA, TOMOKO</creatorcontrib><creatorcontrib>VAN DEN KEYBUS, FRANS M. A</creatorcontrib><creatorcontrib>VAN ROOSBROECK, YVES E. M</creatorcontrib><title>PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP</title><description>An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. [SOLUTION] A pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgNiAwK8vfxB1Kevp4unn6uCo5-LgpIomAxF9cgzzDHEM8w12CF4FCn4BDPkNAQVxeFcM8QDwXnSGcfT2cFR19PP38F9yD_0AAeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBoYmZuaWnuZGFMhBIAn6MxQw</recordid><startdate>20080827</startdate><enddate>20080827</enddate><creator>DE BRUYN, MARCEL F. L</creator><creator>YAMAGUCHI, MIKAKO</creator><creator>BONGARTZ, JEAN-PIERRE A. M</creator><creator>KENNIS, LUDO E.J</creator><creator>HENDRICKX, ROBERT J. M</creator><creator>OKUBO, TAKETOSHI</creator><creator>LUYCKX, MARCEL G. M</creator><creator>NAKAZATO, ATSURO</creator><creator>NOZAWA, DAI</creator><creator>TAMITA, TOMOKO</creator><creator>VAN DEN KEYBUS, FRANS M. A</creator><creator>VAN ROOSBROECK, YVES E. M</creator><scope>EVB</scope></search><sort><creationdate>20080827</creationdate><title>PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP</title><author>DE BRUYN, MARCEL F. L ; YAMAGUCHI, MIKAKO ; BONGARTZ, JEAN-PIERRE A. M ; KENNIS, LUDO E.J ; HENDRICKX, ROBERT J. M ; OKUBO, TAKETOSHI ; LUYCKX, MARCEL G. M ; NAKAZATO, ATSURO ; NOZAWA, DAI ; TAMITA, TOMOKO ; VAN DEN KEYBUS, FRANS M. A ; VAN ROOSBROECK, YVES E. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1467997B83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2008</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DE BRUYN, MARCEL F. L</creatorcontrib><creatorcontrib>YAMAGUCHI, MIKAKO</creatorcontrib><creatorcontrib>BONGARTZ, JEAN-PIERRE A. M</creatorcontrib><creatorcontrib>KENNIS, LUDO E.J</creatorcontrib><creatorcontrib>HENDRICKX, ROBERT J. M</creatorcontrib><creatorcontrib>OKUBO, TAKETOSHI</creatorcontrib><creatorcontrib>LUYCKX, MARCEL G. M</creatorcontrib><creatorcontrib>NAKAZATO, ATSURO</creatorcontrib><creatorcontrib>NOZAWA, DAI</creatorcontrib><creatorcontrib>TAMITA, TOMOKO</creatorcontrib><creatorcontrib>VAN DEN KEYBUS, FRANS M. A</creatorcontrib><creatorcontrib>VAN ROOSBROECK, YVES E. M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DE BRUYN, MARCEL F. L</au><au>YAMAGUCHI, MIKAKO</au><au>BONGARTZ, JEAN-PIERRE A. M</au><au>KENNIS, LUDO E.J</au><au>HENDRICKX, ROBERT J. M</au><au>OKUBO, TAKETOSHI</au><au>LUYCKX, MARCEL G. M</au><au>NAKAZATO, ATSURO</au><au>NOZAWA, DAI</au><au>TAMITA, TOMOKO</au><au>VAN DEN KEYBUS, FRANS M. A</au><au>VAN ROOSBROECK, YVES E. M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP</title><date>2008-08-27</date><risdate>2008</risdate><abstract>An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. [SOLUTION] A pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1467997B8
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T20%3A52%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DE%20BRUYN,%20MARCEL%20F.%20L&rft.date=2008-08-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1467997B8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true